Authors
Latest:
Medication Adherence Changes Following Value-Based Insurance DesignValue-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
Latest:
Bending the Curve Through Health Reform ImplementationAuthors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Latest:
Out-of-Pocket Healthcare Expenditure Burdens Among Nonelderly Adults With HypertensionAmong nonelderly adults receiving hypertension treatment, 13.1% had high burdens, meaning that healthcare expenditures accounted for more than 20% of their income.
Latest:
Association of Care Management Intensity With Healthcare Utilization in an All-Condition Care Management ProgramHigher intensity of care management in an all-condition program addressing care coordination and care barriers was associated with increased healthcare utilization among Medicaid and Medicare patients.
Latest:
Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use DisorderCOVID-19–driven telehealth exposure positively shifted physician respondents’ perceptions of telehealth effectiveness, and most are likely to continue use if temporary telehealth regulatory flexibility is permanently extended.
Latest:
Statin Adherence and Mortality in Patients Enrolled in a Secondary Prevention ProgramEnrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Latest:
Electronic Alerts and Clinician Turnover: The Influence of User AcceptanceUsers' acceptance of electronic health record-based asynchronous alerts can negatively impact provider satisfaction, intentions to quit, and ultimately turnover.
Latest:
US Internists' Awareness and Use of Overtreatment Guidelines: A National SurveyIn a national survey, US internists reported high levels of adoption of overtreatment guidelines; despite this fact, they also reported recommending services targeted by the overtreatment guidelines.
Latest:
Health Plan—Provider Accountable Care Partnerships: How Have They Evolved?Although health plan accountable care models have evolved provider readiness, data, analytics, and the use of performance measurement are important components of plan-provider partnerships.
Latest:
Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.
Latest:
Project ECHO: An Effective Means of Increasing Palliative Care CapacityThis article provides insight on the work of 7 of Project ECHO’s replicating partners from around the world who are implementing the ECHO model to address the knowledge gap that underlies integrated palliative care crisis.
Latest:
An Assessment of the CHIP/Medicaid Quality Measure for ADHDConcerns regarding the quality measure for attention-deficit/hyperactivity disorder may limit its usefulness and its ability to promote improvement efforts.
Latest:
Differences in the Clinical Recognition of Depression in Diabetes Patients: The Diabetes Study of Northern California (DISTANCE)Depression often goes unrecognized in primary care among symptomatic diabetes patients, especially in some minorities.
Latest:
Improving Laboratory Monitoring of Medications: An Economic Analysis Alongside a Clinical TrialAlthough some interventions may enhance medication safety, an electronic medical record reminder to providers may not be an efficient use of resources.
Latest:
Changes in Cardiovascular Care Provision After the Affordable Care ActThe authors evaluated whether the 2010 Affordable Care Act was associated with changes in physicians’ provision of preventive cardiovascular services.
Latest:
Recommendations for the Role of Clinical Pathways in an Era of Personalized MedicineWe offer recommendations for the development and design of clinical pathways in an effort to establish a set of normative criteria that creates trust and transparency.
